GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of what changed for me between week 95 and week 43 — 56 comments in the full submission. View in context.
3.5k
c/glp1science·submitted 2 years ago by u/employer_carveout

what changed for me between week 95 and week 43

Speculationbranch of 10 comments

Right, the mechanism question again, but with numbers this time. I have 18 data points over 18 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 56 comments →

This branch

10 comments, started 2 years ago
u/incretin_ivyMOD348 points·2 years ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/hassan_castellanos282 points·2 years ago

do not extrapolate rodent data to human dosing without saying so

replysharereportpermalink
u/ismael_chukwu272 points·2 years ago

This is correct. Rodent data is investigational, not predictive.

replysharereportpermalink
u/employer_carveoutOP152 points·2 years ago

Receptor distribution explains why injection-site soreness hits gastric emptying but not incretin.

replysharereportpermalink
u/emeka_chowdhury33 points·2 years ago

glucagon-receptor contribution is appetite for dual and triple agonism

replysharereportpermalink
u/trialwatch_theotrial nerd8 points·2 years ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/annika_fonseca483 points·2 years ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/gastric_emptying_g393 points·2 years ago

incretin physiology is appetite, the mechanism layer

replysharereportpermalink
u/karma_irrelevant416 points·2 years ago

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

replysharereportpermalink
u/slow_logbook127 points·2 years ago

cite the paper: journal, year, first author, links optional

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.